Cat.#: ACPP-1227
| Despition | Pax2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg | inquiry |
| ACPP-1598 | Rat SIRPA Protein (AC1598) | 2 µg | inquiry |
| ACPP-1791 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1791) | 100 µg | inquiry |
| ACPP-1552 | Human CDNF Protein (AC1552) | 5 µg | inquiry |
| ACPP-1262 | CXCR4 Blocking Peptide (AC1262) | 250 µg | inquiry |
| ACPP-1121 | Recombinant Human GFAP Protein (AC1121) | 25 µl | inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
| ACPP-1327 | Dopamine Receptor D1 Blocking Peptide (AC1327) | 250 µg | inquiry |
| ACPP-1676 | Human RLBP1 Protein (AC1676) | 5 µg | inquiry |
| ACPP-1692 | Human GLUL Protein (AC1692) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.